Viewing Study NCT02782403


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-01-04 @ 4:21 AM
Study NCT ID: NCT02782403
Status: TERMINATED
Last Update Posted: 2020-11-19
First Post: 2016-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module